Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia

by Asou, N., Mitsuya, H., Yanagida, M., Huang, L., Ito, Y., Osato, M., Shigesada, K., Yamamoto, M.
Published 2011

Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia

by Asou, N., Mitsuya, H., Yanagida, M., Huang, L., Ito, Y., Osato, M., Shigesada, K., Yamamoto, M.
Published 2012

Akt-Induced Phosphorylation of N-CoR at Serine 1450 Contributes to Its Misfolded Conformational Dependent Loss (MCDL) in Acute Myeloid Leukemia of the M5 Subtype

by Nin, D.S., Ali, A.B., Okumura, K., Asou, N., Chen, C.-S., Chng, W.J., Khan, M.
Published 2014

Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis

by Jacob, B., Osato, M., Yamashita, N., Wang, C.Q., Ito, Y., Taniuchi, I., Littman, D.R., Asou, N.
Published 2011

Cleavage of misfolded nuclear receptor corepressor confers resistance to unfolded protein response-induced apoptosis

by Ng, A.P.P., Fong, J.H., Nin, D.S., Chen, C.-S., Pervaiz, S., Khan, M., Hirpara, J.L., Asou, N.
Published 2011

Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice

by Ito, Y., Yamashita, N., Osato, M., Yanagida, M., Shigesada, K., Huang, L., Kogan, S.C., Iwasaki, M., Nakamura, T., Asou, N.
Published 2011

Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice

by Ito, Y., Yamashita, N., Osato, M., Yanagida, M., Shigesada, K., Huang, L., Kogan, S.C., Iwasaki, M., Nakamura, T., Asou, N.
Published 2012

Dual mutations in the AML1 and FLT 3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype

by Matsuno, N., Nanri, T., Mitsuya, H., Asou, N., Osato, M., Yamashita, N., Yanagida, M., Ito, Y., Shigesada, K., Fukushima, T., Motoji, T., Kusumoto, S., Towatari, M., Suzuki, R., Naoe, T., Nishii, K., Ohno, R.
Published 2011

Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm

by Kubota, S., Tokunaga, K., Umezu, T., Yokomizo-Nakano, T., Sun, Y., Oshima, M., Tan, K.T., Yang, H., Kanai, A., Iwanaga, E., Asou, N., Maeda, T., Nakagata, N., Iwama, A., Ohyashiki, K., Osato, M., Sashida, G.
Published 2021

Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm (Nature Communications, (2019),...

by Kubota, S., Tokunaga, K., Umezu, T., Yokomizo-Nakano, T., Sun, Y., Oshima, M., Tan, K.T., Yang, H., Kanai, A., Iwanaga, E., Asou, N., Maeda, T., Nakagata, N., Iwama, A., Ohyashiki, K., Osato, M., Sashida, G.
Published 2021

Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML

by Powell, J.A., Thomas, D., Barry, E.F., Kok, C.H., McClure, B.J., Tsykin, A., To, L.B., Brown, A., Lewis, I.D., Herbert, K., Goodall, G.J., Speed, T.P., Asou, N., Jacob, B., Osato, M., Haylock, D.N., Nilsson, S.K., D'Andrea, R.J., Lopez, A.F., Guthridge, M.A.
Published 2014